Compassionate access to cannabis for kids

Meanwhile, a trial for chemotherapy patients is progressing through ethics and regulatory approvals and is expected to being towards the end of this year, confirms the NSW Health Department. This research will aim to treat chemotherapy-induced nausea and vomiting using oral cannabis-derived capsules containing THC and CBD, developed and supplied by Canadian medicinal cannabis company Tilray.

Read more in the Australian Journal of Pharmacy